ReviewFrontiers in pharmacology2022

Application and Prospect of CRISPR/Cas9 Technology in Reversing Drug Resistance of Non-Small Cell Lung Cancer.

Lu Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.